Stay updated on Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.

Latest updates to the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.6.4 and removes Revision: v3.6.3. This updates the page to reflect the latest software release and the corresponding history record.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new revision entry, Revision: v3.6.3, was added to the study record history, updating the version history from v3.6.2. This reflects an administrative update to the record rather than changes to study data.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision label (v3.6.2) is added to the history, replacing the previous v3.6.0 entry. This reflects an update to the page's revision metadata rather than substantive study information.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study history now includes a new revision entry labeled v3.6.0 and the removal of the previous v3.5.5 entry. A note stating 'No longer looking for participants' was added, indicating that recruitment has ended.SummaryDifference0.2%

- Check58 days agoChange DetectedThe history log now shows a new revision entry (v3.5.5) and removes the previous revision (v3.5.4), indicating an update to the study history documentation.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now shows a new site revision label v3.5.4 added to the history, replacing the previous v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.